NATUS MEDICAL INC

NTUSUnited States

28 filed reports · 459 financial concepts

Latest figures

Group totals as stated in the company’s own filed reports, each with a link to its report. The change is against the same period a year earlier.

Latest fiscal year

Revenue

$473M

FY2021 · to Dec 31, 2021

up +13.9% vs $416M

10-K

Net income

$13.2M

FY2021 · to Dec 31, 2021

a year earlier: -$16.6M

10-K

Operating income

$23.8M

FY2021 · to Dec 31, 2021

a year earlier: -$20.2M

10-K

Latest quarter

Revenue

$120M

Q1 FY2022 · to Mar 31, 2022

up +4.2% vs $115M

10-Q

Net income

$1.9M

Q1 FY2022 · to Mar 31, 2022

down −20.6% vs $2.4M

10-Q

Operating income

$4.18M

Q1 FY2022 · to Mar 31, 2022

down −7.5% vs $4.52M

10-Q

Filed reports

28 reports · Jun 2015 to Mar 2022

Each report counts once it has at least one extracted financial fact.

Report typeReportsFactsPeriods
Quarterly · 10-QSEC EDGAR203,850Jun 2015 to Mar 2022
Annual · 10-KSEC EDGAR63,386Dec 2015 to Dec 2021
Annual · 10-K/ASEC EDGAR1495Dec 2017
Quarterly · 10-Q/ASEC EDGAR1178Sep 2017

Documents

PeriodTypePeriod endPublishedFactsSource
FY2022 Q110-Q2022-03-312022-05-06366Open
FY202110-K2021-12-312022-02-251,041Open
FY2021 Q310-Q2021-09-302021-11-05273Open
FY2021 Q210-Q2021-06-302021-08-06223Open
FY2021 Q110-Q2021-03-312021-05-07173Open
FY202010-K2020-12-312021-02-26561Open
FY2020 Q310-Q2020-09-302020-11-04203Open
FY2020 Q210-Q2020-06-302020-08-04166Open
FY2020 Q110-Q2020-03-312020-05-06168Open
FY201910-K2019-12-312020-03-02479Open
FY2019 Q310-Q2019-09-302019-11-06250Open
FY2019 Q210-Q2019-06-302019-08-07221Open

Financial data

459 concepts · 7,909 facts

Each concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.

Financial456 concepts · 7,381 facts · Dec 2013 to Mar 2022

  • Allocated share based compensation expense42 · Dec 2013 to Mar 2022
  • Amortization of intangible assets42 · Dec 2013 to Mar 2022
  • Cash and cash equivalents at carrying value42 · Dec 2013 to Mar 2022
  • Comprehensive income net of tax42 · Dec 2013 to Mar 2022
  • Depreciation42 · Dec 2013 to Mar 2022
  • Foreign currency transaction gain loss before tax42 · Dec 2013 to Mar 2022
  • General and administrative expense (US GAAP)42 · Dec 2013 to Mar 2022
  • Gross profit (US GAAP)42 · Dec 2013 to Mar 2022
  • Income tax expense benefit42 · Dec 2013 to Mar 2022
  • Net income loss42 · Dec 2013 to Mar 2022
  • Nonoperating income expense42 · Dec 2013 to Mar 2022
  • Operating expenses (US GAAP)42 · Dec 2013 to Mar 2022
  • Operating income loss42 · Dec 2013 to Mar 2022
  • Other nonoperating income expense42 · Dec 2013 to Mar 2022
  • Product warranty accrual42 · Dec 2013 to Mar 2022
  • Research and development expense42 · Dec 2013 to Mar 2022
  • Restructuring charges42 · Dec 2013 to Mar 2022
  • Revenue42 · Dec 2013 to Mar 2022
  • Selling and marketing expense (US GAAP)42 · Dec 2013 to Mar 2022
  • Interest expense (US GAAP)41 · Dec 2013 to Mar 2022
  • Depreciation depletion and amortization40 · Dec 2013 to Mar 2022
  • Increase decrease in accounts payable40 · Dec 2013 to Mar 2022
  • Increase decrease in accounts receivable40 · Dec 2013 to Mar 2022
  • Increase decrease in accrued liabilities40 · Dec 2013 to Mar 2022

Segment2 concepts · 445 facts · Dec 2013 to Mar 2022

  • Market data revenue323 · Mar 2014 to Mar 2022
  • Revenue122 · Dec 2013 to Dec 2021

Geography1 concept · 83 facts · Dec 2013 to Mar 2022

  • Revenue83 · Dec 2013 to Mar 2022

Segments

528 facts

Figures broken down by business line, region, product or another axis the company reports on.

Statement business segments8 members · 445 facts

  • Neurology Products [Member]92 · Dec 2013 to Mar 2019
  • Newborn Care Products [Member]92 · Dec 2013 to Mar 2019
  • Newborn Care Products72 · Dec 2017 to Mar 2022
  • Neurology Products70 · Dec 2017 to Mar 2022
  • Audiology Products41 · Mar 2018 to Mar 2022
  • Otometrics [Member]36 · Mar 2016 to Mar 2019
  • OtometricsProducts [Member]34 · Dec 2015 to Dec 2021
  • Other Products:8 · Mar 2021 to Mar 2022

Statement geographicalus-gaap:StatementGeographicalAxis3 members · 44 facts

  • United States [Member]23 · Dec 2013 to Mar 2019
  • Foreign Countries [Member]15 · Mar 2014 to Mar 2019
  • Foreign countries [Member]6 · Dec 2013 to Dec 2018

Statement geographicalsrt:StatementGeographicalAxis3 members · 39 facts

  • United States [Member]21 · Dec 2017 to Mar 2022
  • International13 · Mar 2018 to Mar 2022
  • Foreign countries [Member]5 · Dec 2017 to Dec 2021

Text from filings

Management commentary and risk factors, extracted from SEC filings only.

No commentary or risk-factor text for this company.

Earnings calls

Transcripts with management claims and analyst questions, one per fiscal period.

No earnings-call transcripts for this company.

Executive media

Podcasts, interviews and conference appearances by the company's executives, with their claims.

No media appearances for this company.

Ask about this company in your AI model

Connect FactIQ to Claude, ChatGPT or another AI model (how to install), then paste this prompt.

Use FactIQ to get the revenue, net income and operating income of NATUS MEDICAL INC (NTUS) from its filed reports, for the last five fiscal years and the latest quarter or half year. Link each figure to its filing, and chart the trend.

Works once FactIQ is connected

Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Nov 20, 2026) and refreshed every few hours.

NATUS MEDICAL INC (NTUS): FY2021 revenue $473M · FactIQ